Seeing Is Believing
Currently out of the existing stock ratings of Courtney Breen, 17 are a HOLD (47.22%), 19 are a BUY (52.78%).
Analyst Courtney Breen, currently employed at BERNSTEIN, carries an average stock price target met ratio of 86.36% that have a potential upside of 15.77% achieved within 184 days.
Courtney Breen’s has documented 71 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 14-Jul-2026.
Analyst best performing recommendations are on AMGN (AMGEN).
The best stock recommendation documented was for AMGN (AMGEN) at 1/20/2026. The price target of $335 was fulfilled within 1 day with a profit of $6.28 (1.91%) receiving and performance score of 19.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2020
$282
$22.64 (8.73%)
$273
8 days ago
(22-Jul-2026)
14/17 (82.35%)
$28.7 (11.33%)
409
Hold Since 15-Jul-2026
$260
$0.64 (0.25%)
$276
15 days ago
(15-Jul-2026)
19/21 (90.48%)
$15.89 (6.51%)
284
Hold Since 07-Jan-2026
$260
$0.64 (0.25%)
$230
17 days ago
(13-Jul-2026)
2/3 (66.67%)
$12 (4.84%)
89
Buy Since 05-Feb-2024
$300
$40.64 (15.67%)
$258
17 days ago
(13-Jul-2026)
16/17 (94.12%)
$52 (20.97%)
318
Buy Since 25-Feb-2026
$280
$20.64 (7.96%)
$260
20 days ago
(10-Jul-2026)
6/7 (85.71%)
$31.92 (12.87%)
161
Which stock is Courtney Breen is most bullish on?
What Year was the first public recommendation made by Courtney Breen?